<DOC>
	<DOCNO>NCT01891292</DOCNO>
	<brief_summary>The purpose study determine whether enalapril antioxidant therapy ( N-Acetylcysteine ) effective reduce microalbuminuria child sickle cell disease progression sickle nephropathy</brief_summary>
	<brief_title>Efficacy Antioxidant Therapy Compared With Enalapril Sickle Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Homozygous S sickle cell disease Diagnosed newborn screening determine persistent microalbuminuria satisfy criterion microalbuminuria screen parental consent Asymptomatic bacteriuria screen urine culture On Hydroxyurea therapy Preexisting complication SCD would meet local criterion HU therapy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>